1,349
Views
10
CrossRef citations to date
0
Altmetric
Original Research

PPARγ-activation increases intestinal M1 macrophages and mitigates formation of serrated adenomas in mutant KRAS mice

ORCID Icon, , ORCID Icon, , ORCID Icon, , , , , , , & show all
Article: e1423168 | Received 20 Sep 2017, Accepted 22 Dec 2017, Published online: 01 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Peng Du, Ming Chen, Changcai Deng & Chonggui Zhu. (2022) microRNA-199a downregulation alleviates hyperuricemic nephropathy via the PPARγ/β-catenin axis. Journal of Receptors and Signal Transduction 42:4, pages 373-381.
Read now
Xin Wang, Jin Deng, Chongxiang Xiong, Haishan Chen, Qin Zhou, Yue Xia, Xiaofei Shao & Hequn Zou. (2020) Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model. Drug Design, Development and Therapy 14, pages 2221-2233.
Read now

Articles from other publishers (8)

Elke Burgermeister. (2023) Mitogen-Activated Protein Kinase and Nuclear Hormone Receptor Crosstalk in Cancer Immunotherapy. International Journal of Molecular Sciences 24:17, pages 13661.
Crossref
Mélissa Prat, Kimberley Coulson, Clément Blot, Godefroy Jacquemin, Mathilde Romano, Marie-Laure Renoud, Mohamad AlaEddine, Augustin Le Naour, Hélène Authier, Mouna Chirine Rahabi, Khaddouj Benmoussa, Marie Salon, Mélissa Parny, Jean-Pierre Delord, Gwenaël Ferron, Lise Lefèvre, Bettina Couderc & Agnès Coste. (2023) PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression. Journal for ImmunoTherapy of Cancer 11:8, pages e007031.
Crossref
Bo Li, Li Qian, Li Pi & Xianxi Meng. (2023) A therapeutic role of exosomal lncRNA H19 from adipose mesenchymal stem cells in cutaneous wound healing by triggering macrophage M2 polarization. Cytokine 165, pages 156175.
Crossref
Florian Lüke, Dennis Christoph Harrer, Pan Pantziarka, Tobias Pukrop, Lina Ghibelli, Christopher Gerner, Albrecht Reichle & Daniel Heudobler. (2022) Drug Repurposing by Tumor Tissue Editing. Frontiers in Oncology 12.
Crossref
S. Yuvaraj & B.R. Prashantha Kumar. (2022) Peroxisome Proliferator-activated Receptor-γ As A Novel and Promising Target For Treating Cancer Via Regulation of Inflammation: A Brief Review. Mini-Reviews in Medicinal Chemistry 22:1, pages 3-14.
Crossref
Begoña Alburquerque-González, Fernando F. López-Calderón, María Dolores López-Abellán, Ángel Esteban-Gil, José García-Solano & Pablo Conesa-Zamora. (2020) Biology and Therapeutic Targets of Colorectal Serrated Adenocarcinoma; Clues for a Histologically Based Treatment against an Aggressive Tumor. International Journal of Molecular Sciences 21:6, pages 1991.
Crossref
Jan Korbecki, Rafał Bobiński & Mieczysław Dutka. (2019) Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors. Inflammation Research 68:6, pages 443-458.
Crossref
Tobias Gutting, Elke Burgermeister, Nicolai Härtel & Matthias P. Ebert. (2019) Checkpoints and beyond – Immunotherapy in colorectal cancer. Seminars in Cancer Biology 55, pages 78-89.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.